Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02564120 · ClinicalTrials.gov registry record
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
A clinical trial of Prostate Cancer and Cancer of the Prostate, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 1,556
- Enrollment target
- 1
- Study location
NCT02564120: Completed study of Prostate Cancer and Cancer of the Prostate, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT02564120 is a study of Prostate Cancer and Cancer of the Prostate that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,556 participants, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02564120, a study of Prostate Cancer and Cancer of the Prostate, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 1,556 participants
- Enrollment target
- 1
- Study location
Study Summary
NC ProCESS is a cohort of patients from diverse backgrounds diagnosed with early prostate cancer, who were enrolled from January 2011-June 2013. These patients were recruited throughout North Carolina, and also in partnership with institutions across the country. Patients enrolled before they start treatment, and are then followed prospectively through treatment and then afterwards. This observational study collects information on quality of life, cancer control, and health care received inclusive of treatment and management of subsequent effects including complications and recurrence. The objective of this study is to examine comparative outcomes among different modern prostate cancer treatment options in this cohort of patients.
Primary Outcome
Prostate Cancer Symptom Indices (PCSI) - measures treatment-related morbidity and adverse effects and is comprised of 4 functional scales measuring Sexual Dysfunction, Bowel Problems, Urinary Incontinence, and Urinary Obstruction/Irritation. Four parallel distress indices measure distress from symptoms. In each index, patient answers are converted to a score from 0 (no symptom/distress) to 100 (maximum symptoms/distress). A 5-10 point difference in QOL is considered "clinically meaningful."
Conditions Studied
Study Locations (1)
North Carolina
- The University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,556 participants |
| Start Date | 2011-01 |
| Est. Completion | 2018-12-31 |
What the finished NCT02564120 record still lists
NCT02564120 is an observational study that tracks outcomes without assigning an intervention. Its 1,556 participants enrollment target places it among the larger protocols in the corpus, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (157% higher).
The record links to 4 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02564120 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02564120 about?
NCT02564120 is a clinical study titled "North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)". NC ProCESS is a cohort of patients from diverse backgrounds diagnosed with early prostate cancer, who were enrolled from January 2011-June 2013. These patients were recruited throughout North Carolina, and also in partnership with institutions across the country. Patients enrolled before they start ...
What is the current status of trial NCT02564120?
This trial is currently completed. The enrollment target is 1,556 participants. The study started on 2011-01. Estimated completion is 2018-12-31.
What conditions does trial NCT02564120 study?
This clinical trial studies the following conditions: Prostate Cancer, Cancer of the Prostate, Cancer Of Prostate, Prostatic Cancer.
Who is sponsoring clinical trial NCT02564120?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02564120 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02564120's enrollment target sits among peer trials
1,556 33rd of 735 higher than 703 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia